Vascular leakage induced by exposure to arsenic via increased production of NO, hydroxyl radical and peroxynitrite

Microvascular Research

Volumn 75, Issue 3, 2008, Pages 373-380

  Chen, Shih Chieh ^a   Chen, Wei Chi ^b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Arsenic toxicity; Hydroxyl radical; NO; Peroxynitrite; Vascular leakage

Indexed keywords

AMINOGUANIDINE; ARSENITE SODIUM; DIMETHYLTHIOUREA; EVANS BLUE; HYDROXYL RADICAL; N(G) NITROARGININE METHYL ESTER; NITROGEN OXIDE; PEROXYNITRITE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASSAY; BLOOD VESSEL; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STAINING;

ANIMALS; ARSENITES; BLOOD VESSELS; CAPILLARY PERMEABILITY; CARBON; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; EVANS BLUE; FREE RADICAL SCAVENGERS; GUANIDINES; HYDROXYL RADICAL; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAVENOUS; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PEROXYNITROUS ACID; RATS; RATS, SPRAGUE-DAWLEY; SKIN; SODIUM COMPOUNDS; THIOUREA; TYROSINE;

RATTUS;

EID: 41949085623     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2007.12.004     Document Type: Article

References (38)

1. Baldwin A.L., Thurston G., and al Naemi H. Inhibition of nitric oxide synthesis increases venular permeability and alters endothelial actin cytoskeleton. Am. J. Physiol. 274 (1998) H1776-H1784
2. Barchowsky A., Klei L.R., Dudek E.J., Swartz H.M., and James P.E. Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite. Free Radic. Biol. Med. 27 (1999) 1405-1412
3. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., and Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 1620-1624
4. Bjork J., del Maestro R.F., and Arfors K.E. Evidence for participation of hydroxyl radical in increased microvascular permeability. Agents Actions Suppl. 7 (1980) 208-213
5. Chen C.J., Chen C.W., Wu M.M., and Kuo T.L. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br. J. Cancer. 66 (1992) 888-892
6. Chen C.J., and Wang C.J. Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res. 50 (1990) 5470-5474
7. Chen S.C., Tsai M.H., Wang H.J., Yu H.S., and Chang L.W. Vascular permeability alterations induced by arsenic. Hum. Exp. Toxicol. 23 (2004) 1-7
8. Chen S.C., Tsai M.H., Wang H.J., Yu H.S., and Chang L.W. Involvement of substance P and neurogenic inflammation in arsenic-induced early vascular dysfunction. Toxicol. Sci. 95 (2007) 82-88
9. Chiou H.Y., Huang W.I., Su C.L., Chang S.F., Hsu Y.H., and Chen C.J. Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke 28 (1997) 1717-1723
10. Chou W.C., Jie C., Kenedy A.A., Jones R.J., Trush M.A., and Dang C.V. Role of NADPH oxidase in arsenic-induced reactive oxygen species formation and cytotoxicity in myeloid leukemia cells. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 4578-4583
11. Fujii E., Irie K., Ogawa A., Ohba K., and Muraki T. Role of nitric oxide and prostaglandins in lipopolysaccharide-induced increase in vascular permeability in mouse skin. Eur. J. Pharmacol. 297 (1996) 257-263
12. Gurr J.R., Yih L.H., Samikkannu T., Bau D.T., Lin S.Y., and Jan K.Y. Nitric oxide production by arsenite. Mutat. Res. 533 (2003) 173-182
13. Hughes S.R., Williams T.J., and Brain S.D. Evidence that endogenous nitric oxide modulates oedema formation induced by substance P. Eur. J. Pharmacol. 191 (1990) 481-484
14. Ialenti A., Ianaro A., Moncada S., and Di Rosa M. Modulation of acute inflammation by endogenous nitric oxide. Eur. J. Pharmacol. 211 (1992) 177-182
15. Kao Y.H., Yu C.L., Chang L.W., and Yu H.S. Low concentrations of arsenic induce vascular endothelial growth factor and nitric oxide release and stimulate angiogenesis in vitro. Chem. Res. Toxicol. 16 (2003) 460-468
16. Klabunde R.E., and Anderson D.E. Role of nitric oxide and reactive oxygen species in platelet-activating factor-induced microvascular leakage. J. Vasc. Res. 39 (2002) 238-245
17. Kubes P., and Granger D.N. Nitric oxide modulates microvascular permeability. Am. J. Physiol. 262 (1992) H611-H615
18. Kumagai Y., and Pi J. Molecular basis for arsenic-induced alteration in nitric oxide production and oxidative stress: implication of endothelial dysfunction. Toxicol. Appl. Pharmacol. 198 (2004) 450-457
19. Kurose I., Kubes P., Wolf R., Anderson D.C., Paulson J., Miyasaka M., and Granger D.N. Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage. Circ. Res. 73 (1993) 164-171
20. Laszlo F., and Whittle B.J. Actions of isoform-selective and non-selective nitric oxide synthase inhibitors on endotoxin-induced vascular leakage in rat colon. Eur. J. Pharmacol. 334 (1997) 99-102
21. Laszlo F., Whittle B.J., Evans S.M., and Moncada S. Association of microvascular leakage with induction of nitric oxide synthase: effects of nitric oxide synthase inhibitors in various organs. Eur. J. Pharmacol. 283 (1995) 47-53
22. Lee K.S., Kim S.R., Park S.J., Park H.S., Min K.H., Lee M.H., Jin S.M., Jin G.Y., Yoo W.H., and Lee Y.C. Hydrogen peroxide induces vascular permeability via regulation of vascular endothelial growth factor. Am. J. Respir. Cell Mol. Biol. 35 (2006) 190-197
23. Liu S.X., Athar M., Lippai I., Waldren C., and Hei T.K. Induction of oxyradicals by arsenic: implication for mechanism of genotoxicity. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 1643-1648
24. Lynn S., Gurr J.R., Lai H.T., and Jan K.Y. NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells. Circ. Res. 86 (2000) 514-519
25. Nguyen L.S., Villablanca A.C., and Rutledge J.C. Substance P increases microvascular permeability via nitric oxide-mediated convective pathways. Am. J. Physiol. 268 (1995) R1060-R1068
26. Pereira F.E., Coffin J.D., and Beall H.D. Activation of protein kinase C and disruption of endothelial monolayer integrity by sodium arsenite-potential mechanism in the development of atherosclerosis. Toxicol. Appl. Pharmacol. 220 (2007) 164-177
27. Persson J., Ekelund U., and Grande P.O. Nitric oxide and prostacyclin play a role in the regulation of microvascular protein and hydraulic permeability in cat skeletal muscle. Microcirculation 10 (2003) 233-243
28. Rumbaut R.E., and Huxley V.H. Similar permeability responses to nitric oxide synthase inhibitors of venules from three animal species. Microvasc. Res. 64 (2002) 21-31
29. Shi H., Hudson L.G., Ding W., Wang S., Cooper K.L., Liu S., Chen Y., Shi X., and Liu K.J. Arsenite causes DNA damage in keratinocytes via generation of hydroxyl radicals. Chem. Res. Toxicol. 17 (2004) 871-878
30. Smith K.R., Klei L.R., and Barchowsky A. Arsenite stimulates plasma membrane NADPH oxidase in vascular endothelial cells. Am. J. Physiol., Lung Cell. Mol. Physiol. 280 (2001) L442-L449
31. Thomas D.J., Styblo M., and Lin S. The cellular metabolism and systemic toxicity of arsenic. Toxicol. Appl. Pharmacol. 176 (2001) 127-144
32. Tsai M.H., Chen S.C., Wang H.J., Yu H.S., and Chang L.W. A mouse model for the study of vascular permeability changes induced by arsenic. Toxicol Mech Method 15 (2005) 433-437
33. Tseng W.P. Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic. Environ. Health Perspect. 19 (1977) 109-119
34. Tsou T.C., Tsai F.Y., Hsieh Y.W., Li L.A., Yeh S.C., and Chang L.W. Arsenite induces endothelial cytotoxicity by down-regulation of vascular endothelial nitric oxide synthase. Toxicol. Appl. Pharmacol. 208 (2005) 277-284
35. Wang S.L., Chiou J.M., Chen C.J., Tseng C.H., Chou W.L., Wang C.C., Wu T.N., and Chang L.W. Prevalence of non-insulin-dependent diabetes mellitus and related vascular diseases in southwestern arseniasis-endemic and nonendemic areas in Taiwan. Environ. Health Perspect. 111 (2003) 155-159
36. Yu H.S., Sheu H.M., Ko S.S., Chiang L.C., Chien C.H., Lin S.M., Tserng B.R., and Chen C.S. Studies on blackfoot disease and chronic arsenism in southern Taiwan: with special reference to skin lesions and fluorescent substances. J. Dermatol. 11 (1984) 361-370
37. Yuan Y., Granger H.J., Zawieja D.C., and Chilian W.M. Flow modulates coronary venular permeability by a nitric oxide-related mechanism. Am. J. Physiol. 263 (1992) H641-H646
38. Zhang X.M., and Ellis E.F. Superoxide dismutase reduces permeability and edema induced by hypertension in rats. Am. J. Physiol. 259 (1990) H497-H503